Complete financial analysis of Community Health Systems, Inc. (CYH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Community Health Systems, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Lumi Rental Company (4262.SR) Income Statement Analysis – Financial Results
- Brembo S.p.A. (BRE.MI) Income Statement Analysis – Financial Results
- Saptak Chem and Business Limited (SCBL.BO) Income Statement Analysis – Financial Results
- Ledyard Financial Group, Inc. (LFGP) Income Statement Analysis – Financial Results
- Johnson & Johnson (JNJ.DE) Income Statement Analysis – Financial Results
Community Health Systems, Inc. (CYH)
About Community Health Systems, Inc.
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.49B | 12.21B | 12.37B | 11.79B | 13.21B | 14.16B | 15.35B | 18.44B | 19.44B | 18.64B | 13.00B | 13.03B | 11.91B | 11.40B | 12.11B | 10.84B | 7.13B | 4.37B | 3.74B | 3.33B | 2.83B | 2.20B | 1.69B | 1.34B | 1.08B |
| Cost of Revenue | 7.41B | 7.31B | 7.28B | 7.37B | 8.10B | 8.74B | 10.05B | 11.64B | 12.04B | 11.48B | 8.21B | 8.08B | 1.83B | 1.77B | 6.53B | 5.85B | 3.84B | 2.25B | 1.93B | 1.74B | 912.80M | 1.38B | 323.81M | 259.47M | 209.08M |
| Gross Profit | 5.08B | 4.91B | 5.08B | 4.42B | 5.11B | 5.42B | 5.31B | 6.80B | 7.40B | 7.16B | 4.79B | 4.95B | 10.07B | 9.63B | 5.58B | 4.99B | 3.29B | 2.11B | 1.80B | 1.59B | 1.92B | 817.99M | 1.37B | 1.08B | 870.87M |
| Gross Profit Ratio | 40.69% | 40.18% | 41.11% | 37.45% | 38.70% | 38.26% | 34.55% | 36.90% | 38.06% | 38.41% | 36.82% | 38.00% | 84.60% | 84.46% | 46.08% | 46.08% | 46.13% | 48.42% | 48.25% | 47.80% | 67.80% | 37.17% | 80.88% | 80.60% | 80.64% |
| Research & Development | 80.00M | 85.00M | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 2.49B | 1.54B | 1.23B | 1.10B | 1.49B | 1.84B | 1.06B | 825.29M | 683.96M |
| Other Expenses | 3.73B | 3.70B | 3.35B | 2.91B | 3.91B | 4.19B | 4.70B | 5.28B | 5.53B | 5.24B | 3.50B | 3.47B | 4.89B | 4.60B | 4.26B | 1.71B | 316.22M | 191.57M | 167.67M | 158.26M | 145.75M | 120.45M | 119.67M | 97.62M | 81.65M |
| Operating Expenses | 4.13B | 4.01B | 3.66B | 3.24B | 4.23B | 4.53B | 5.09B | 5.73B | 5.99B | 5.68B | 3.78B | 3.74B | 9.00B | 8.51B | 4.51B | 9.86B | 2.80B | 1.73B | 1.40B | 1.25B | 1.63B | 1.96B | 1.18B | 922.92M | 765.61M |
| Cost & Expenses | 11.53B | 11.32B | 10.94B | 10.62B | 12.33B | 13.27B | 15.14B | 17.36B | 18.03B | 17.16B | 12.00B | 11.82B | 10.84B | 10.28B | 11.04B | 9.86B | 6.64B | 3.99B | 3.33B | 2.99B | 2.54B | 1.96B | 1.50B | 1.18B | 974.70M |
| Interest Income | 2.00M | 2.00M | 3.00M | 3.00M | 3.00M | 7.00M | 11.00M | 0.00 | 0.00 | 0.00 | 2.98M | 0.00 | 4.65M | 1.76M | 3.56M | 7.06M | 8.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 832.00M | 858.00M | 885.00M | 1.03B | 1.04B | 976.00M | 931.00M | 962.00M | 973.00M | 972.00M | 615.15M | 622.93M | 649.06M | 653.68M | 648.96M | 658.98M | 364.53M | 102.30M | 94.61M | 77.86M | 71.09M | 62.86M | 94.55M | 0.00 | 0.00 |
| Depreciation & Amortization | 505.00M | 534.00M | 540.00M | 558.00M | 608.00M | 700.00M | 861.00M | 1.10B | 1.17B | 1.19B | 782.68M | 725.56M | 657.67M | 609.84M | 566.54M | 506.69M | 332.58M | 188.77M | 166.16M | 158.38M | 143.77M | 118.22M | 119.67M | 97.62M | 81.65M |
| EBITDA | 1.54B | 1.74B | 1.93B | 2.02B | 1.23B | 970.00M | -1.00B | 307.00M | 2.57B | 2.42B | 1.63B | 1.86B | 1.78B | 1.77B | 1.66B | 1.53B | 824.19M | 569.23M | 571.70M | 500.85M | 434.54M | 359.73M | 308.71M | 252.74M | 186.91M |
| EBITDA Ratio | 12.36% | 11.79% | 16.07% | 14.78% | 11.39% | 11.37% | 7.11% | 12.03% | 13.61% | 14.57% | 14.05% | 15.18% | 14.54% | 15.13% | 13.72% | 13.75% | 11.86% | 13.04% | 15.29% | 14.94% | 15.33% | 16.35% | 18.23% | 18.90% | 17.31% |
| Operating Income | 957.00M | 821.00M | 1.40B | 1.13B | 896.00M | 208.00M | -1.88B | -860.00M | 1.34B | 1.38B | 899.76M | 1.21B | 1.13B | 1.11B | 1.07B | 983.57M | 485.69M | 380.46M | 405.53M | 338.87M | 290.77M | 241.51M | 189.04M | 155.11M | 105.26M |
| Operating Income Ratio | 7.66% | 6.72% | 11.34% | 9.55% | 6.78% | 1.47% | -12.23% | -4.66% | 6.88% | 7.40% | 6.92% | 9.29% | 9.53% | 9.78% | 8.83% | 9.07% | 6.81% | 8.72% | 10.85% | 10.17% | 10.26% | 10.98% | 11.16% | 11.60% | 9.75% |
| Total Other Income/Expenses | -750.00M | -472.00M | -903.00M | -704.00M | -1.08B | -923.00M | -955.00M | -855.00M | -926.00M | -997.00M | -611.14M | -706.35M | -660.94M | -606.49M | -622.54M | -607.34M | -378.39M | -104.10M | -94.61M | -72.44M | -71.09M | -62.86M | -94.55M | -127.37M | -116.49M |
| Income Before Tax | 207.00M | 349.00M | 499.00M | 422.00M | -430.00M | -715.00M | -2.83B | -1.72B | 411.00M | 342.00M | 305.86M | 503.77M | 473.55M | 508.43M | 446.13M | 336.14M | 102.90M | 278.16M | 310.92M | 260.22M | 219.68M | 178.65M | 94.50M | 27.74M | -11.24M |
| Income Before Tax Ratio | 1.66% | 2.86% | 4.03% | 3.58% | -3.26% | -5.05% | -18.45% | -9.30% | 2.11% | 1.83% | 2.35% | 3.87% | 3.98% | 4.46% | 3.68% | 3.10% | 1.44% | 6.37% | 8.32% | 7.81% | 7.75% | 8.12% | 5.58% | 2.07% | -1.04% |
| Income Tax Expense | 191.00M | 170.00M | 131.00M | -185.00M | 160.00M | -11.00M | -449.00M | -104.00M | 116.00M | 82.00M | 88.59M | 157.50M | 137.65M | 159.99M | 141.33M | 129.48M | 43.00M | 106.68M | 120.78M | 102.00M | 88.21M | 73.39M | 45.94M | 18.17M | 5.55M |
| Net Income | -133.00M | 179.00M | 368.00M | 511.00M | -590.00M | -788.00M | -2.46B | -1.72B | 158.00M | 92.00M | 141.20M | 265.64M | 201.95M | 279.98M | 243.15M | 218.30M | 30.29M | 168.26M | 167.54M | 151.43M | 131.47M | 99.98M | 44.74M | 9.57M | -16.79M |
| Net Income Ratio | -1.06% | 1.47% | 2.98% | 4.33% | -4.47% | -5.57% | -16.02% | -9.33% | 0.81% | 0.49% | 1.09% | 2.04% | 1.70% | 2.46% | 2.01% | 2.01% | 0.42% | 3.85% | 4.48% | 4.54% | 4.64% | 4.54% | 2.64% | 0.72% | -1.55% |
| EPS | -1.02 | 1.39 | 2.90 | 4.42 | -5.19 | -6.99 | -22.00 | -15.55 | 1.38 | 0.82 | 1.51 | 2.98 | 2.24 | 3.05 | 2.68 | 2.34 | 0.32 | 1.77 | 1.89 | 1.58 | 1.34 | 1.02 | 0.51 | 0.14 | -0.31 |
| EPS Diluted | -1.02 | 1.38 | 2.82 | 4.38 | -5.19 | -6.99 | -22.00 | -15.54 | 1.37 | 0.82 | 1.51 | 2.96 | 2.23 | 3.01 | 2.66 | 2.32 | 0.32 | 1.75 | 1.79 | 1.51 | 1.30 | 1.00 | 0.50 | 0.14 | -0.31 |
| Weighted Avg Shares Out | 130.39M | 128.81M | 126.75M | 115.49M | 113.74M | 112.73M | 111.77M | 110.71M | 114.00M | 112.00M | 92.63M | 89.24M | 89.97M | 91.72M | 90.62M | 93.37M | 93.52M | 94.98M | 88.60M | 95.64M | 98.39M | 98.42M | 88.38M | 67.61M | 54.55M |
| Weighted Avg Shares Out (Dil) | 130.45M | 130.06M | 130.60M | 116.54M | 113.74M | 112.73M | 111.77M | 110.73M | 115.00M | 113.00M | 93.82M | 89.81M | 90.67M | 92.95M | 91.52M | 94.29M | 94.64M | 96.23M | 98.58M | 100.29M | 101.13M | 108.38M | 90.25M | 69.19M | 54.55M |
Will Low Patient Days Impact Community Health (CYH) Q1 Earnings?
Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.
Community Health Systems to Webcast First Quarter 2024 Conference Call
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its first quarter 2024 conference call. The Company will issue a press release announcing its results on Wednesday, April 24, 2024, after the regular close of...
Community Health Systems Addresses Health Disparities through Doctors' Day Donations and Second Annual Jars of Love Peanut Butter Drive
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) (CHS) announced today that, in honor of Doctors' Day, its affiliated hospitals will donate more than $250,000 to charitable organizations that are addressing social determinants of health. This is the second consecutive...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health, Inc. - CYH
NEW YORK , March 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
New Strong Sell Stocks for March 26th
ACNB, ALX and CYH have been added to the Zacks Rank #5 (Strong Sell) List on March 26, 2023.
Community Health Systems (CYH) Up 17.2% Since Last Earnings Report: Can It Continue?
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock?
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health, Inc. - CYH
NEW YORK , March 19, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Community Health Systems, Inc. (CYH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)---- $CYH #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Community Health Systems, Inc. (“Community Health” or “the Company”) (NYSE: CYH). Investors who purchased Community Health securities are encouraged to obtain...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health, Inc. - CYH
NEW YORK , March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Community Health (CYH), Cost Plus Drugs Unite to Lower Drug Cost
Community Health (CYH) collaborates with Cost Plus Drug to reduce drug costs and shortages.
Source: https://incomestatements.info
Category: Stock Reports